The Strategic Action includes a set of annual biomedical research promotion programs promoted by the Carlos III Health Institute, essential for research in the healthcare world of our country. The programs include grants for the development of research projects, for mobility, and contracts of diverse scope and grants for participation in Networks, Consortiums and Platforms of the Carlos III Health Institute itself.
In the Resolution of the ISCIII of September 20, which proposes the provisional relationship for the granting of Río Hortega and Sara Borrell Contracts for the 2019 Call of the Strategic Action in Health, IDIVAL has received concessions in both programs, specifically:
This type of aid is of special importance insofar as they contribute to the recruitment and training of talent in our environment within the IDIVAL Research Groups.

Biomedical research and innovation are only possible thanks to everyone’s collaboration. This is how we move forward in improving the health of patients and the wider community